Denzel, Dominik
Runge, Kimon http://orcid.org/0000-0002-0263-4360
Feige, Bernd http://orcid.org/0000-0002-9436-1258
Pankratz, Benjamin
Pitsch, Karoline
Schlump, Andrea
Nickel, Kathrin http://orcid.org/0000-0001-9863-317X
Voderholzer, Ulrich
Tebartz van Elst, Ludger
Domschke, Katharina http://orcid.org/0000-0002-2550-9132
Schiele, Miriam A.
Endres, Dominique http://orcid.org/0000-0001-7322-1195
Article History
Received: 31 January 2022
Revised: 29 April 2023
Accepted: 26 June 2023
First Online: 3 July 2023
Competing interests
: DD: None. KR: None. BF: None. BP: None. KP: None. AS: None. KN: None. UV: None. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. KD: Steering Committee Neurosciences, Janssen. Speaker fees from Janssen. MAS: None. DE: None.